Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HMGN1 Protein | 1 | 2018 | 3 | 0.650 |
Why?
|
| Trisomy | 1 | 2018 | 240 | 0.580 |
Why?
|
| Down Syndrome | 1 | 2018 | 227 | 0.520 |
Why?
|
| Transcription, Genetic | 3 | 2020 | 3330 | 0.470 |
Why?
|
| Re-Epithelialization | 1 | 2014 | 9 | 0.470 |
Why?
|
| Lipocalins | 1 | 2014 | 54 | 0.470 |
Why?
|
| Acute-Phase Proteins | 1 | 2014 | 84 | 0.460 |
Why?
|
| Keratinocytes | 1 | 2014 | 244 | 0.430 |
Why?
|
| Wilms Tumor | 1 | 2015 | 301 | 0.420 |
Why?
|
| Genetic Markers | 1 | 2015 | 1073 | 0.410 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 367 | 0.400 |
Why?
|
| Repressor Proteins | 2 | 2015 | 1716 | 0.360 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 626 | 0.360 |
Why?
|
| Wound Healing | 1 | 2014 | 770 | 0.330 |
Why?
|
| Skin | 1 | 2014 | 1283 | 0.310 |
Why?
|
| Spliceosomes | 2 | 2021 | 76 | 0.300 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 1132 | 0.290 |
Why?
|
| Cell Movement | 1 | 2014 | 2468 | 0.270 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 4104 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 5775 | 0.200 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 3109 | 0.190 |
Why?
|
| Supratentorial Neoplasms | 1 | 2021 | 77 | 0.180 |
Why?
|
| Transcription Factor RelA | 1 | 2021 | 184 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2020 | 64 | 0.180 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2020 | 103 | 0.170 |
Why?
|
| Immunity | 1 | 2021 | 353 | 0.160 |
Why?
|
| Ependymoma | 1 | 2021 | 264 | 0.160 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2018 | 85 | 0.150 |
Why?
|
| Nucleosomes | 1 | 2018 | 150 | 0.150 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2021 | 1385 | 0.150 |
Why?
|
| Genes, myc | 2 | 2018 | 371 | 0.150 |
Why?
|
| Acetylation | 1 | 2018 | 516 | 0.140 |
Why?
|
| Lysine | 1 | 2018 | 426 | 0.140 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2020 | 467 | 0.130 |
Why?
|
| Mutation | 1 | 2015 | 15904 | 0.130 |
Why?
|
| Receptors, Androgen | 1 | 2020 | 854 | 0.120 |
Why?
|
| Genome | 1 | 2018 | 689 | 0.120 |
Why?
|
| Models, Genetic | 1 | 2018 | 1161 | 0.120 |
Why?
|
| Lipocalin-2 | 1 | 2014 | 77 | 0.120 |
Why?
|
| RNA | 1 | 2018 | 1058 | 0.110 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 1421 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2018 | 2414 | 0.100 |
Why?
|
| Neuroblastoma | 1 | 2018 | 706 | 0.100 |
Why?
|
| Histones | 1 | 2018 | 1512 | 0.090 |
Why?
|
| Cell Line | 1 | 2018 | 5326 | 0.090 |
Why?
|
| Gene Amplification | 3 | 2021 | 765 | 0.090 |
Why?
|
| Animals | 8 | 2021 | 61554 | 0.090 |
Why?
|
| beta Catenin | 1 | 2014 | 689 | 0.090 |
Why?
|
| Sirolimus | 1 | 2014 | 830 | 0.090 |
Why?
|
| Transcriptome | 1 | 2018 | 1960 | 0.080 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2014 | 841 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 1008 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 4994 | 0.070 |
Why?
|
| Mice | 6 | 2021 | 35477 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 7054 | 0.070 |
Why?
|
| Introns | 2 | 2021 | 461 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2020 | 4965 | 0.070 |
Why?
|
| Phenotype | 1 | 2018 | 6503 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2021 | 5416 | 0.070 |
Why?
|
| RNA Splicing | 2 | 2021 | 362 | 0.070 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 14873 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2015 | 6240 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2014 | 5692 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2021 | 12044 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2021 | 841 | 0.050 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 106 | 0.050 |
Why?
|
| Breast Neoplasms | 2 | 2015 | 16238 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 151 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2021 | 702 | 0.040 |
Why?
|
| Humans | 7 | 2021 | 271081 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 2395 | 0.040 |
Why?
|
| Mice, Nude | 2 | 2015 | 4331 | 0.040 |
Why?
|
| Twist-Related Protein 1 | 1 | 2018 | 132 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2015 | 3924 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2015 | 2453 | 0.030 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 23 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 2428 | 0.030 |
Why?
|
| Splicing Factor U2AF | 1 | 2015 | 47 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2020 | 1739 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2018 | 489 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2018 | 3435 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 116 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2015 | 125 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2015 | 151 | 0.030 |
Why?
|
| Kinetics | 1 | 2018 | 2209 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2015 | 5317 | 0.030 |
Why?
|
| Oncogenes | 1 | 2018 | 698 | 0.030 |
Why?
|
| Doxycycline | 1 | 2014 | 179 | 0.030 |
Why?
|
| Binding Sites | 1 | 2018 | 2249 | 0.030 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2014 | 347 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 547 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 378 | 0.030 |
Why?
|
| Chromatin | 1 | 2018 | 1044 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 9044 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2015 | 1684 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2014 | 667 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1072 | 0.020 |
Why?
|
| Estradiol | 1 | 2014 | 828 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 3204 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2014 | 875 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2015 | 1130 | 0.020 |
Why?
|
| Cell Survival | 1 | 2015 | 3058 | 0.020 |
Why?
|
| Carcinogenesis | 1 | 2014 | 1034 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 1704 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 1536 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 7320 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2050 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2014 | 2177 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 4906 | 0.020 |
Why?
|
| Apoptosis | 1 | 2021 | 7755 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 3606 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 2112 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 6343 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 2617 | 0.020 |
Why?
|
| Female | 4 | 2021 | 149115 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 5417 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 33807 | 0.010 |
Why?
|
| Male | 1 | 2020 | 128479 | 0.010 |
Why?
|